Regulatory News
May 8, 2018 / 9:54 PM / 9 months ago

BRIEF-EyePoint Pharmaceuticals Reports Q3 Loss Per Share $0.15

1 Min Read

May 8 (Reuters) - EyePoint Pharmaceuticals Inc:

* EYEPOINT PHARMACEUTICALS REPORTS FISCAL THIRD QUARTER 2018 RESULTS

* Q3 REVENUE VIEW $723,000 — THOMSON REUTERS I/B/E/S

* Q3 EARNINGS PER SHARE VIEW $-0.13 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below